Krüppel-like factor 9 loss-of-expression in human endometrial carcinoma links altered expression of growth-regulatory genes with aberrant proliferative response to estrogen

Biology of Reproduction

Volumn 85, Issue 2, 2011, Pages 378-385

  Simmons, Christian D ^a   Pabona, John Mark P ^a,b   Heard, Melissa E ^a   Friedman, Theodore M ^a   Spataro, Michael T ^b   Godley, Amy L ^b   Simmen, Frank A ^a   Burnett, Alexander F ^b   Simmen, Rosalia C M ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Endometrial carcinoma; Endometrium; Estradiol estradiol receptor; Ishikawa cells; Kr ppel like factor 9; Telomerase; Uterine cancer; Uterus

Indexed keywords

DNA METHYLTRANSFERASE 1; ESTROGEN; ESTROGEN RECEPTOR ALPHA; HISTONE DEACETYLASE 3; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 4; KRUPPEL LIKE FACTOR 9; MESSENGER RNA; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN FOS; SMALL INTERFERING RNA; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION;

ADULT; AGED; CARCINOMA; CELL PROLIFERATION; CELLS, CULTURED; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MIDDLE AGED;

MURINAE;

EID: 80052541853     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.110.090654     Document Type: Article

References (54)

1. American Cancer Society. Cancer Facts & Figures 2009. Atlanta: American Cancer Society; 2009.
2. Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 2000; 13:295-308.
3. Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T, Wang H. Molecular cues to implantation. Endocr Rev 2004; 25:341-373.
4. Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/ thyroid receptor superfamily members. Annu Rev Biochem 1993; 63:451-486.
5. Franco HL, Jeong JW, Tsai SY, Lydon JP, DeMayo FJ. In vivo analysis of progesterone receptor action in the uterus during embryo implantation. Semin Cell Dev Biol 2008; 19:178-186.
6. Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001; 276:36869-36872.
7. Lonard DM, O'Malley BW. The expanding cosmos of nuclear receptor coactivators. Cell 2006; 125:411-414.
8. Green KA, Carroll JS. Estrogen-receptor-mediated transcription and the influence of cofactors and chromatin state. Nat Rev Cancer 2007; 7:713-722.
9. Suske G, Bruford E, Philipsen S. Mammalian SP/KLF transcription factors: bring in the family. Genomics 2005; 85:551-556.
10. Zhang D, Zhang X-L, Michel FJ, Blum JL, Simmen FA, Simmen RCM. Direct interaction of the Krüppel-like family (KLF) member BTEB1 and progesterone receptor mediates progesterone-responsive gene expression in endometrial epithelial cells. Endocrinology 2002; 141:62-73.
11. Zhang XL, Zhang D, Michel FJ, Blum JL, Simmen FA, Simmen RCM. Selective interactions of Krü ppel-like factor 9/basic transcription elementbinding protein with progesterone receptor isoforms A and B determine transcriptional activity of progesterone-responsive genes in endometrial epithelial cells. J Biol Chem 2003; 278:21474-21482.
12. Simmen RCM, Eason RR, McQuown JR, Linz AL, Kang T-J, Chatman L, Till SR, Fujii-Kuriyama Y, Simmen FA, Oh SP. Subfertility, uterine hypoplasia, and partial progesterone resistance in mice lacking the Krüppel-like factor 9/basic transcription element-binding protein-1 (Bteb1) gene. J Biol Chem 2004; 279:29286-29294.
13. Velarde MC, Zeng Z, McQuon JR, Simmen FA, Simmen RCM. Krüppellike factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells. Mol Endocrinol 2007; 21:2988-3001.
14. Pabona JMP, Velarde MC, Zeng Z, Simmen FA, Simmen RCM. Nuclear receptor coregulator Krüppel-like factor 9 and prohibitin 2 expression in estrogen-induced epithelial cell proliferation in the mouse uterus. J Endocrinol 2009; 200:63-73.
15. Simmons C, Pabona J, Zeng Z, Velarde M, Gaddy D, Simmen F, Simmen R. Response of adult mouse uterus to early disruption of estrogen receptor-α signaling is influenced by Krü ppel-like factor 9. J Endocrinol 2010; 205:147-157.
16. Morita M, Kobayashi A, Yamashita T, Shimanuki T, Nakajima O, Takahasi S, Ikegami S, Inokuchi K, Yamashita K, Yamamoto M. Functional analysis of basic transcription element binding protein by gene targeting technology. Mol Cell Biol 2003; 23:2489-2500.
17. Du H, Sarno J, Taylor HS. HOXA10 inhibits Kruppel-like factor 9 expression in the human endometrial epithelium. Biol Reprod 2010; 83:205-211
18. Velarde MC, Geng Y, Eason RR, Simmen FA, Simmen RC. Null mutation of Kruppel-like factor 9/basic transcription element binding protein-1 alters peri-implantation uterine development in mice. Biol Reprod 2005; 73:472-481.
19. Zeng Z, Velarde MC, Simmen FA, Simmen RCM. Delayed parturition and altered myometrial progesterone receptor isoform A expression in mice null for Krüppel-like factor 9. Biol Reprod 2008; 78:1029-1037.
20. Pabona JM, Zeng Z, Simmen FA, Simmen RC. Functional differentiation of uterine stromal cells involves cross-regulation between bone morphogenetic protein 2 and Krü ppel-like factor (KLF) family members KLF9 and KLF13. Endocrinology 2010; 151:3396-3406.
21. Simmen FA, Su Y, Xiao R, Zeng Z, Simmen RC. The Krü ppel-like factor 9 (KLF9) network in HEC-1-A endometrial carcinoma cells suggests the carcinogenic potential of dys-regulated KLF9 expression. Reprod Biol Endocrinol 2008; 6:41.
22. Lee B, Du H, Taylor HS. Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium. Biol Reprod 2009; 80:79-85.
23. Rackow BW, Taylor HS. Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity. Fertil Steril 2010; 93:2027-2034.
24. Velarde MC, Iruthayanathan M, Eason RR, Zhang D, Simmen FA, Simmen RCM. Progesterone receptor transactivation of the secretory leukocyte protease inhibitor gene in Ishikawa endometrial epithelial cells involves recruitment of Krüppel-like factor 9/basic transcription element binding protein-1. Endocrinology 2006; 147:1969-1978.
25. Hapangama DK, Turner MA, Drury JA, Martin-Ruiz C, Von Zglinicki T, Farquharson RG, Quenby S. Endometrial telomerase shows specific expression patterns in different types of reproductive failure. Reprod Biomed Online 2008; 17:416-424.
26. Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol 2006; 24:4783-4791.
27. Zhang XL, Simmen FA, Michel FJ, Simmen RC. Increased expression of the Zn-finger transcription factor BTEB1 in human endometrial cells is correlated with distinct cell phenotype, gene expression patterns, and proliferative responsiveness to serum and TGF-beta1. Mol Cell Endocrinol 2001; 181:81-96.
28. McConnell BB, Ghaleb AM, Nandan MO, Yang VW. The diverse functions of Krü ppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 2007; 29:549-557.
29. Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, Kaestner KH, Biggs JR, Kraft AS, Yang VW. The gut-enriched Krüppel-like factor (Krüppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem 2000; 275:18391-18398.
30. Rowland BD, Bernards R, Peeper DS. The KLF4 tumor suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 2005; 7:1074-1082.
31. Evans PM, Chen X, Zhang W, Liu C. KLF4 interacts with beta-catenin/ TCF4 and blocks p300/CBP recruitment by beta-catenin. Mol Cell Biol 2010; 30:372-381.
32. Xu J, Lu B, Xu F, Gu H, Fang Y, Huang Q, Lai M. Dynamic downregulation of Krüppel-like factor 4 in colorectal adenoma-carcinoma sequence. J Cancer Res Clin Oncol 2008; 134:891-898.
33. Kang L, Lu B, Xu J, Hu H, Lai M. Down-regulation of Krü ppel-like factor 9 in human colorectal cancer. Pathol Int 2008; 58:334-338.
34. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277:955-959.
35. Yokoyama Y, Takahashi Y, Morishita S, Hashimoto M, Niwa K, Tamaya T. Telomerase activity in the human endometrium throughout the menstrual cycle. Mol Hum Reprod 1998; 4:173-177.
36. Geserick C, Tejera A, González-Suárez E, Klatt P, Blasco MA. Expression of mTert in primary murine cells links the growth-promoting effects of telomerase to transforming growth factor-beta signaling. Oncogene 2006; 25:4310-4319.
37. Yan P, Benhattar J, Seelentag W, Stehle JC, Bosman FT. Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol 2004; 121:391-397.
38. Oshita T, Nagai N, Ohama K. Expression of telomerase reverse transcriptase mRNA and its quantitative analysis in human endometrial cancer. Int J Oncol 2000; 17:1225-1230.
39. Lehner R, Enomoto T, McGregor JA, Shroyer AL, Haugen BR, Pugazhenthi U, Shroyer KR. Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinomas and in normal endometrium. Gynecol Oncol 2001; 84:120-125.
40. Misiti S, Nanni S, Fontemaggi G, Cong YS, Wen J, Hirte HW, Piaggio G, Sacchi A, Pontecorvi A, Bachetti S, Farsetti A. Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol Cell Biol 2000; 20:3764-3771.
41. Cha Y, Kwon SJ, Seol W, Park KS. Estrogen receptor-alpha mediates the effects of estradiol on telomerase activity in human mesenchymal stem cells. Mol Cells 2008; 26:454-458.
42. Calado RT, Yewdell WT, Wilkerson KL, Regal JA, Kajigaya S, Stratakis CA, Young NS. Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood 2009; 114:2236-2243.
43. Artandi SE, DePinho RA. Telomeres and telomerase in cancer. Carcinogenesis 2010; 31:9-18.
44. Blasco MA. Telomerase beyond telomeres. Nat Rev Cancer 2002; 2:627-633.
45. Flores I, Cayuela ML, Blasco MA. Effects of telomerase and telomere length on epidermal stem cells behavior. Science 2005; 309:1253-1256.
46. Risinger JI, Hayes AK, Berchuck A, Barrett JC. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 1997; 57:4736-4738.
47. Mutter GL, Baak JPA, Fitzgerald JT, Gray R, Neuberg D, Kust G, Gentleman R, Gullans S, Wei L, Wilcox M. Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol 2001; 83:177-185.
48. Lacey JV Jr, Mutter GL, Ronnett BM, Ioffe OB, Duggan MA, Rush BB, Glass AG, Richesson DA, Chatterjee N, Langholz B, Sherman ME. PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma. Cancer Res 2008; 68:6014-6020.
49. Zhou C, Bae-Jump VL, Whang YE, Gehrig PA, Boggess JF. The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels. Gynecol Oncol 2006; 101:305-310.
50. Seeber LM, Zweemer RP, Marchioni L, Massuger LF, Smit VT, van Baal WM, Verheijen RH, van Diest PJ. Methylation profiles of endometrioid and serous endometrial cancers. Endocr Relat Cancer 2010; 17:663-673.
51. Sasaki M, Kaneuchi M, Fujimoto S, Tanaka Y, Dahiya R. Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers. Mol Cell Endocrinol 2003; 202:201-207.
52. Ignatov A, Bischoff J, Ignatov T, Schwarzenau C, Krebs T, Kuester D, Costa SD, Roessner A, Semczuk A, Schneider-Stock R. APC promoter hypermethylation is an early event in endometrial tumorigenesis. Cancer Sci 2010; 101:321-327.
53. Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 2009; 114:121-127.
54. Pei H, Yao Y, Yang Y, Liao K, Wu JR. Krüppel-like factor KLF9 regulates PPARγ transactivation at the middle stage of adipogenesis. Cell Death Differ 2011; 18:315-327.